As of Sep 20
| +0.81 / +1.23%|
The 8 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 76.00, with a high estimate of 90.00 and a low estimate of 61.00. The median estimate represents a +14.06% increase from the last price of 66.63.
The current consensus among 9 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.